Harm Reduction

The generation of aerosols from patients with COVID-19 has long been a concern in healthcare.

The research involved 26 healthy "occasional cannabis users" [1] in a double-blind study. Each participant acted as their own controls, along with vaping cannabis combinations, and then let loose on the roads for a 100-km ride.

Tomorrow the FDA will consider emergency use approval of Pfizer’s COVID-19 vaccine. The report that the agency will be basing its decision upon can be found here.

When it comes to staying at home, what is the most significant driver, our government, or our beliefs? A working paper from the National Bureau of Economic Research teases out the different effects of fear and policy in lockdowns.

Lockdowns are nothing more than widespread, complete social distancing. The science here is clear that eliminating direct contacts significantly reduces disease transmission.

The source of today's information comes from a series of interviews with various members of what constitutes our Strategic National Stockpile (SNS), an amalgamation of many government agencies.

Given that these reports come, in no small degree, from health professionals, it is unlikely that a large number of serious adverse effects, like anaphylactic reactions and deaths, go unreported. Maybe a little fever or rash gets lost.

I've written in the late winter and early spring about what was deemed an essential service.

The first study looks at physicians' changing payment patterns between 2014, the first year of the Sunshine Act's Open Payments database, and 2018.